Jan Bauer

Dr. Bauer is recognized as a leading lawyer for his private equity and corporate M&A work in top legal publications, including the JUVE Handbook, Chambers Global, Chambers Europe, The Legal 500 and IFLR1000. Clients characterize him in those rankings as a “class act” and recognize him as “one of the heavy hitters in the market.”  

Dr. Bauer’s representations advising private equity clients, prior to joining Skadden, include:

• American Industrial Partners in the combination of its Goss printing business with manroland web systems;
• Apax Partners in its acquisition of Azelis Group;
• Baillie Gifford in its investment in CureVac;
• Blackstone in numerous transactions, including in its:
  • €1.6 billion sale of the Meerwind offshore windfarm to China Three Gorges;
  • €1 billion acquisition of Armacell;
  • acquisition of a 45 percent stake in Leica Camera followed by a public takeover offer;
  • €700 million acquisition of Jack Wolfskin;
  • €2.68 billion acquisition of a minority stake in Deutsche Telekom; and
  • €3.1 billion public-to-private acquisition of Celanese AG;
• Deutsche Beteiligungs AG in several transactions, including its acquisition of Braun Group;
• Eurazeo in various transactions, including in connection with its investment and disposal of APCOA Group;
• Goldman Sachs in its:
  • €270 million acquisition of Continental Bakeries;
  • investment in windeln.de and the subsequent IPO of windeln.de; and
  • investment in Mister Spex;
• KKR in various transactions, including in its:
  • US$1.3 billion acquisition of Hitachi Koki;
  • €1 billion acquisition of the global diabetes care business of Bayer AG;
  • €1 billion sale, together with Goldman Sachs, of a minority stake in KION to Weichai Power through a primary share issuance and the subsequent IPO of KION; and
  • US$2.38 billion acquisition of Capsugel from Pfizer;
• One Equity Partners in various transactions, including in its:
  • US$200 million acquisition of the Peroxygens business from FMC Corporation; and
  • €420 million investment in Schoeller Arca Systems;
• Ontario Teachers Pension Plan in its:
  • €4.6 billion acquisition, together with Partners Group and CDPQ, of Techem; and
  • €2.6 billion acquisition, together with BC Partners and PSP, of CeramTec;
• Soros Fund Management in various transactions, including in its €200 million investment in Evonik; and
• TSG Consumer Partners in its:
  • investment in Canyon Bicycles; and
  • investment in Zoeva.

Dr. Bauer’s recent representations advising corporate clients, prior to joining Skadden, include:

• ATOS SE in its €600 million acquisition of Unify Group from Siemens AG and Gores Group;
• Celanese Corporation in various transactions, including in its acquisition of SO.F.TER. Group;
• HeidelbergCement AG in various transactions, including in its:
  • €2.4 billion sale of its maxit business to Saint Gobain;
  • sale of its lime business to Rheinkalk; and
  • sale of its German and Swiss calcium silicate business to H+H for an undisclosed amount;
• Helaba in various transactions, including its sale of Hannover Leasing, an asset manager with €13.6 billion assets under management, to CORESTATE;
• Infineon AG in various transactions, including its US$1 billion sale of its wireless solutions business to Intel;
• KION GROUP AG in various transactions, including in its:
  • US$3.25 billion acquisition of DEMATIC from AEA and OTPP;
  • €271 million sale of a majority stake in its Linde Hydraulik business to Weichai Power; and
  • disposal of its container handling business to Konecranes;
• LEO Pharma in its €675 million acquisition of the dermatology business of Astella;
• Scholz AG in its €1.48 billion restructuring and the investment by Toyota Tshusho Corporation in the company;
• Union Investment in its joint venture with ZBI and the establishment of a €1 billion residential real estate fund; and
• Warner Music in its acquisition of the Spinnin record label.